Institutional Ownership Autolus Therapeutics PLC (AUTL)
This table provides information about the institutional ownership of Autolus Therapeutics PLC (AUTL). We have compiled data on the 100 institutions that hold shares in the stock, with a total of 165 Million shares, which have been reported (via 13F filing form) to have a value of $224 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Wellington Management Group LLP
Boston, MA |
Aug 14, 2025 Q2 2025 |
27,147,035
shares
|
$36.9 Million
0.01% of portfolio
|
Q2 2025
Added 0.2%
|
|
Blackstone Inc
New York, NY |
Aug 14, 2025 Q2 2025 |
20,485,611
shares
|
$27.9 Million
0.22% of portfolio
|
Q4 2022
Added 13.9%
|
|
Mak Capital One LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
16,955,098
shares
|
$23.1 Million
5.54% of portfolio
|
Q2 2025
New holding
|
|
Deep Track Capital, LP
Greenwich, CT |
Aug 14, 2025 Q2 2025 |
16,852,147
shares
|
$22.9 Million
1.36% of portfolio
|
Q2 2025
Reduced 5.59%
|
|
Syncona Portfolio LTD
Guernsey, Channel Islands, X0 |
Aug 07, 2025 Q2 2025 |
16,640,720
shares
|
$22.6 Million
98.24% of portfolio
|
Q4 2024
Reduced 10.31%
|
|
Armistice Capital, LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
12,000,000
shares
|
$16.3 Million
0.48% of portfolio
|
Q2 2025
Added 9.09%
|
|
Tfg Asset Management Gp LTD
Grand Cayman, E9 |
Aug 14, 2025 Q2 2025 |
9,500,000
shares
|
$12.9 Million
5.47% of portfolio
|
Q2 2025
Added 10.47%
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
Aug 14, 2025 Q2 2025 |
4,623,324
shares
|
$6.29 Million
0.56% of portfolio
|
Q1 2024
Added 23.39%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
4,436,102
shares
|
$6.03 Million
0.0% of portfolio
|
Q2 2024
Added 9.37%
|
|
Schroder Investment Management Group
London, X0 |
Aug 13, 2025 Q2 2025 |
3,608,490
shares
|
$4.91 Million
0.01% of portfolio
|
Q1 2025
Added 25.97%
|
|
Laurion Capital Management LP
New York, NY |
Aug 14, 2025 Q2 2025 |
3,316,626
shares
|
$4.51 Million
0.14% of portfolio
|
Q2 2025
Reduced 1.56%
|
|
Axa S.A.
Paris, I0 |
Aug 14, 2025 Q2 2025 |
3,126,167
shares
|
$4.25 Million
0.02% of portfolio
|
Q1 2025
Added 71.33%
|
|
Affinity Asset Advisors, LLC
New York, NY |
Aug 13, 2025 Q2 2025 |
3,045,000
shares
|
$4.14 Million
1.16% of portfolio
|
Q1 2025
Reduced 32.33%
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Aug 14, 2025 Q2 2025 |
2,694,202
shares
|
$3.66 Million
0.0% of portfolio
|
Q2 2025
Reduced 7.1%
|
|
Odey Asset Management Group LTD
London, X0 |
May 15, 2023 Q1 2023 |
2,499,400
shares
|
$3.4 Million
1.52% of portfolio
|
Q4 2022
New holding
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Aug 13, 2025 Q2 2025 |
1,751,200
shares
|
$2.38 Million
0.01% of portfolio
|
Q2 2025
Added 10.55%
|
|
Pendal Group LTD
|
Jan 19, 2023 Q4 2022 |
1,733,391
shares
|
$2.36 Million
0.03% of portfolio
|
Q4 2022
Added 26.46%
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
1,410,104
shares
|
$1.92 Million
0.0% of portfolio
|
Q1 2025
Added 31.6%
|
|
Health Invest Partners Ab
|
Jul 14, 2025 Q2 2025 |
1,105,461
shares
|
$1.5 Million
1.14% of portfolio
|
Q2 2025
Added 130.48%
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Aug 14, 2025 Q2 2025 |
1,004,378
shares
|
$1.37 Million
0.0% of portfolio
|
Q2 2025
Added 431.68%
|
|
Bank Of America Corp
Charlotte, NC |
Aug 14, 2025 Q2 2025 |
975,135
shares
|
$1.33 Million
0.0% of portfolio
|
Q2 2025
Added 2891.67%
|
|
Perpetual LTD
Sydney, New South Wales, C3 |
Jul 11, 2025 Q2 2025 |
829,090
shares
|
$1.13 Million
0.02% of portfolio
|
Q2 2025
Reduced 32.25%
|
|
Alphabet Inc.
Mountain View, CA |
Jul 31, 2025 Q2 2025 |
698,262
shares
|
$949,636
0.1% of portfolio
|
Q2 2020
Reduced 0.16%
|
|
Cetera Investment Advisers
Schaumburg, IL |
Aug 08, 2025 Q2 2025 |
617,172
shares
|
$839,353
0.0% of portfolio
|
Q2 2025
Added 17.59%
|
|
Eversept Partners, LP
New York, NY |
Aug 14, 2025 Q2 2025 |
610,231
shares
|
$829,914
0.14% of portfolio
|
Q2 2025
Added 77.42%
|